Basics Amylyx Pharmaceuticals, Inc. IPO Date: January 7, 2022 Sector: Healthcare Industry: Biotech Market Cap: $1.56B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.41% Avg Daily Range (30 D): $0.43 | 3.15% Avg Daily Range (90 D): $0.37 | 3.04% Institutional Daily Volume Avg Daily Volume: 1.15M Avg Daily Volume (30 D): 1.16M Avg Daily Volume (90 D): 1.37M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 86 Institutional Trades Total Inst.Trades: 1,526 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $1.59M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.3M Avg Closing Trade (30 D): $2.21M Avg Closing Trade (90 D): $2.16M Avg Closing Volume: 154.46K     News Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight Jul 14, 2025 @ 10:26 PM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C. Jul 8, 2025 @ 1:00 AM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C. Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman May 10, 2024 @ 6:01 PM Breaking Down Amylyx Pharma: 9 Analysts Share Thei... Source: Benzinga Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.79 $-.37 $-.46 Diluted EPS $-1.79 $-.37 $-.46 Revenue $ -.67M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -149.28M $ -34.39M $ -41.44M Operating Income / Loss $ -157.34M $ -36.03M $ -42.86M Cost of Revenue $ M $ M $ M Net Cash Flow $ 152.88M $ 166.63M $ -1.68M PE Ratio